[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371953-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371953-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-pelp1-pathway-and-its-importance-in-cancer-treatment-review","The PELP1 Pathway and Its Importance in Cancer Treatment - Review","","Proline-, glutamic acid-, and leucine-rich protein 1 (PELP1) functions as a proto-oncogene scaffolding protein located in both nucleus and cytoplasm. PELP1 supports nuclear receptor signaling, ribosome biogenesis, chromatin modifications, cell-cycle progression, non-genomic signaling, and DNA damage response. Elevated PELP1 expression is reported across multiple solid tumors, correlating with poor survival and suggesting value as a prognostic biomarker and therapeutic target. The review consolidates recent advances in PELP1 biology, emphasizing emergent oncogenic roles and PELP1 inhibitors for cancer treatment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-pelp1-pathway-and-its-importance-in-cancer-treatment-review/371953/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-pelp1-pathway-and-its-importance-in-cancer-treatment-review/371953.png","ImageObject",300,407,{"name":42,"@type":43},"OmBimo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is PELP1 and what role does it play in cancer?","Question",{"text":63,"@type":64},"PELP1 is a proto-oncogene scaffolding protein that supports multiple pathways involved in oncogenic processes, including receptor signaling, ribosome biogenesis, chromatin regulation, and DNA damage response. Its expression is upregulated in several cancers and links to poor survival.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does PELP1 contribute to cellular signaling and gene regulation?",{"text":68,"@type":64},"PELP1 acts as a multifunctional scaffold connecting nuclear receptors and transcription factors to cytoplasmic kinases such as Src, PI3K, and MAPK. It also interacts with chromatin-modifying enzymes that influence histone modifications at gene promoters.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is PELP1 considered a therapeutic target?",{"text":72,"@type":64},"PELP1’s modular motifs and oncogenic activity make it actionable by therapeutic approaches. The review highlights that PELP1 inhibitors are being evaluated to counter its tumor-promoting functions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371953,1790454081,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nThe PELP1 Pathway and Its Importance in Cancer Treatment  \nKhaled Mohamed Nassar 1, Panneerdoss Subbarayalu 2, Suryavathi Viswanadhapalli 1, * and Ratna K. Vadlamudi 1,3, *  \nAcademic Editor: David Puett  \nReceived: 9 November 2025  \nRevised: 6 December 2025  \nAccepted: 8 December 2025  \nPublished: 12 December 2025  \nCitation: Nassar, K.M.; Subbarayalu, P.; Viswanadhapalli, S.; Vadlamudi, R.K. The PELP1 Pathway and Its Importance in Cancer Treatment. Biomolecules 2025, 15, 1729. [https://](https://)[ ](https://)[doi.org/10.3390/biom15121729](doi.org/10.3390/biom15121729)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Obstetrics and Gynecology, University of Texas Health San Antonio, San Antonio, TX 78229, USA; [nassark@livemail.uthscsa.edu](nassark@livemail.uthscsa.edu)  \n2 Greehey Children’s Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA; [subbarayalu@uthscsa.edu](subbarayalu@uthscsa.edu)  \n3 Audie L. Murphy Division, South Texas Veterans Health Care System, San Antonio, TX 78229, USA  \n* [Correspondence: viswanadhapa@uthscsa.edu](Correspondence: viswanadhapa@uthscsa.edu) (S.V.); [vadlamudi@uthscsa.edu](vadlamudi@uthscsa.edu) (R.K.V.); Tel.: +1-(210)-450-3073 (S.V.); +1-(210)-567-4921 (R.K.V.)  \nAbstract  \nProline-, glutamic acid-, and leucine-rich protein 1 (PELP1) is a proto-oncogene that serves as a nuclear and cytoplasmic scaffolding protein. PELP1 plays a critical role in nuclear receptor signaling, ribosome biogenesis, chromatin modifications, cell cycle progression, non-genomic signaling, and DNA damage response. PELP1 expression is upregulated in a variety of cancers, including breast, ovarian, endometrial, prostate, and liver cancers and serves as a prognostic factor for poor survival. PELP1’s structural motifs, unique scaffolding function, and oncogenic activity make it a potential target for a range of therapeutic approaches. This review summarizes the most recent advancements in PELP1 biology, with a particular focus on the emergent oncogenic functions of PELP1 and its inhibitors for the treatment of cancer.  \nKeywords: PELP1; PELP1 inhibitors; Rix complex; oncogene  \n1. Introduction  \nProline-, glutamic acid-, and leucine-rich protein 1 (PELP1) is a multifunctional scaffold protein that acts as a transcriptional coregulator for various nuclear receptors (NRs) and transcription factors [1–3] . PELP1 also serves as an important regulator/mediator of genomic and nongenomic signaling by connecting NRs to cytoplasmic kinases like Src, PI3K, and MAPK [2,4] . PELP1 is an important component of the Rix1 complex and plays a critical role in ribosome biogenesis and new protein synthesis [5–8] . PELP1 interacts with several chromatin-modifying enzymes, such as HDAC2, KDM1A, and CBP/p300, which help histone modifications at gene promoters. Recent research implicates PELP1’s role in cell cycle progression, DNA damage response, stem cell maintenance, metabolic signaling, and immune modulation. PELP1 expression is commonly deregulated in many solid cancers, establishing it as a potential therapeutic target. This review summarizes recent findings regarding the oncogenic functions of PELP1, with an emphasis on the literature published within the past decade, and evaluates therapeutic strategies designed to target this protein.  \n2. PELP1: Structure and Function  \n2.1. Overview of PELP1 Structure  \nPELP1 lacks known enzymatic activity, predicted to function as a scaffolding protein with a theoretical molecular weight of 120 KDa (Figure 1) . Because of the presence of  \nexcess proline and glutamic acid amino acids, it runs as ~160 kDa in Western blots. PELP1 ","cbCaiaQWhb4dLH3l","https://ap.wps.com/l/cbCaiaQWhb4dLH3l","pdf",1889067,21,"English","# Introduction\n# PELP1: Structure and Function\n## Overview of PELP1 Structure","[{\"question\":\"What is PELP1 and what role does it play in cancer?\",\"answer\":\"PELP1 is a proto-oncogene scaffolding protein that supports multiple pathways involved in oncogenic processes, including receptor signaling, ribosome biogenesis, chromatin regulation, and DNA damage response. Its expression is upregulated in several cancers and links to poor survival.\"},{\"question\":\"How does PELP1 contribute to cellular signaling and gene regulation?\",\"answer\":\"PELP1 acts as a multifunctional scaffold connecting nuclear receptors and transcription factors to cytoplasmic kinases such as Src, PI3K, and MAPK. It also interacts with chromatin-modifying enzymes that influence histone modifications at gene promoters.\"},{\"question\":\"Why is PELP1 considered a therapeutic target?\",\"answer\":\"PELP1’s modular motifs and oncogenic activity make it actionable by therapeutic approaches. The review highlights that PELP1 inhibitors are being evaluated to counter its tumor-promoting functions.\"}]","The PELP1 Pathway and Its Importance in Cancer Treatment - Review | PDF",1790193312,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e57144b40be4f62f6863bb02d793056.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d52f3c96f149e41fef89d835d2c77b3.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc23e1347e033f4bf5cebd803c5404df.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b004e128024c9745e95dec0f34baf541.webp",980,1385]